KYMR | Kymera Therapeutics, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	43.28 - 45.94
52 Week Range	18.89 - 53.27
Beta	2.49
Implied Volatility	66.66%
IV Rank	53.99%
Day's Volume	559,063
Average Volume	409,926
Shares Outstanding	64,765,300
Market Cap	2,913,143,194
Sector	Healthcare
Industry	Biotechnology
IPO Date	2020-08-21

Valuation
Profitability
Growth
Health
P/E Ratio	-19.22
Forward P/E Ratio	N/A
EPS	-2.34
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	181
Country	USA
Website	KYMR

Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa, atopic dermatitis, macrophage activation syndrome, general pustular psoriasis, and rheumatoid arthritis; IRAKIMiD program to treat MYD88-mutated diffuse large B cell lymphoma; STAT3 program for the treatment of hematologic malignancies and solid tumors, as well as autoimmune diseases and fibrosis; and MDM2 program to treat hematological malignancies and solid tumors. The company was incorporated in 2015 and is headquartered in Watertown, Massachusetts.

KYMR's peers: AGIO, ARVN, BCAB, BHVN, CCCC, CDXS, CLLS, EXAI, FHTX, GLUE, IKNA, IMAB, IMUX, ITOS, STTK, NRIX, RVMD, IPSC, EWTX, MLYS, CGEM, ELYM, PRLD, KZR, NAUT, SANA, SEER, SWTX, TNGX, VOR, ZNTL

*Chart delayed

Analyzing fundamentals for KYMR we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is bad and Health is passable. For more detailed analysis please see KYMR Fundamentals page.

Watching at KYMR technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, but short-term trend is bearish. More technicals details can be found on KYMR Technicals page.